Readystate Asset Management LP Makes New $1.81 Million Investment in Ventas, Inc. $VTR

Readystate Asset Management LP purchased a new stake in Ventas, Inc. (NYSE:VTR) during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 20,433 shares of the real estate investment trust’s stock, valued at approximately $1,814,000.

A number of other institutional investors also recently modified their holdings of the business. Dynamic Wealth Strategies LLC bought a new position in Ventas in the 1st quarter worth approximately $25,000. Wiser Advisor Group LLC bought a new stake in Ventas during the 3rd quarter valued at $27,000. Silvant Capital Management LLC bought a new stake in Ventas during the 2nd quarter valued at $28,000. Meeder Asset Management Inc. purchased a new stake in shares of Ventas during the second quarter worth $30,000. Finally, IFC & Insurance Marketing Inc. purchased a new stake in shares of Ventas during the fourth quarter worth $30,000. 94.18% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Jefferies Financial Group lifted their price target on Ventas from $97.00 to $100.00 and gave the company a “buy” rating in a research report on Tuesday, May 12th. Barclays increased their price objective on Ventas from $99.00 to $102.00 and gave the stock an “equal weight” rating in a report on Monday, August 31st. Cantor Fitzgerald raised their target price on Ventas from $97.00 to $102.00 and gave the stock an “overweight” rating in a research note on Friday, July 31st. Citigroup lifted their target price on Ventas from $100.00 to $110.00 and gave the company a “buy” rating in a report on Tuesday, August 4th. Finally, Weiss Ratings raised shares of Ventas from a “hold (c+)” rating to a “buy (b-)” rating in a report on Tuesday, July 21st. Fourteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. Based on data from MarketBeat, Ventas currently has a consensus rating of “Moderate Buy” and a consensus price target of $99.00.

Ventas Stock Performance

Ventas stock opened at $90.27 on Tuesday. The stock has a market cap of $46.30 billion, a P/E ratio of 167.17, a PEG ratio of 3.52 and a beta of 0.70. Ventas, Inc. has a fifty-two week low of $66.38 and a fifty-two week high of $101.60. The firm’s fifty day moving average price is $92.96 and its 200-day moving average price is $87.86. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44.

Ventas (NYSE:VTR) last issued its quarterly earnings data on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.96 by $0.01. The company had revenue of $1.73 billion for the quarter, compared to the consensus estimate of $1.68 billion. Ventas had a return on equity of 1.99% and a net margin of 4.08%.The firm’s revenue was up 21.7% compared to the same quarter last year. During the same quarter last year, the business posted $0.87 earnings per share. Equities research analysts forecast that Ventas, Inc. will post 3.89 earnings per share for the current fiscal year.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.